OKLAHOMA CITY, April 04, 2018 -- Federman & Sherwood announces that on March 15, 2018, a class action lawsuit was filed in the United States District Court for the Southern District of New York against Credit Suisse AG and Janus Index & Calculation Services LLC on behalf of a class consisting of investors who purchased or otherwise acquired Credit Suisse VelocityShares Inverse VIX Short Term ETNs (NYSE:XIVH) (“Notes”). The complaint alleges violations of federal securities laws, during the Class Period, which is January 29, 2018 through February 5, 2018.
Plaintiff seeks to recover damages on behalf of all investors who purchased the Notes during the class period and are therefore a member of the Class as described above. However, in order to do so, you must meet certain legal requirements pursuant to the Private Securities Litigation Reform Act of 1995.
If you wish to discuss this action, obtain further information and participate in this or any other securities litigation, or should you have any questions or concerns regarding this notice or preservation of your rights, please contact:
Robin Hester
FEDERMAN & SHERWOOD
10205 North Pennsylvania Avenue
Oklahoma City, OK 73120
Email to: [email protected]
Or, visit the firm’s website at www.federmanlaw.com


Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Washington Post Publisher Will Lewis Steps Down After Layoffs
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence 



